BRCA1/2 assays
NGS
PARP-1i
somatic BRCA
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
09 10 2019
09 10 2019
Historique:
received:
08
08
2019
revised:
04
10
2019
accepted:
04
10
2019
entrez:
12
10
2019
pubmed:
12
10
2019
medline:
12
10
2019
Statut:
epublish
Résumé
In Italy, 5200 new ovarian cancers were diagnosed in 2018, highlighting an increasing need to test women for
Identifiants
pubmed: 31600986
pii: diagnostics9040146
doi: 10.3390/diagnostics9040146
pmc: PMC6963957
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Clin Oncol. 2017 Dec 1;35(34):3800-3806
pubmed: 28820644
Am Soc Clin Oncol Educ Book. 2019 Jan;39:79-86
pubmed: 31099688
Ann Surg Oncol. 2018 Oct;25(10):2925-2931
pubmed: 29998407
Hum Mutat. 2008 Nov;29(11):1282-91
pubmed: 18951446
Diagnostics (Basel). 2019 Aug 01;9(3):null
pubmed: 31374917
Genet Med. 2016 Aug;18(8):842-9
pubmed: 26741410
Health Policy. 2012 Jun;106(1):10-6
pubmed: 22551787
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Int J Mol Sci. 2018 Mar 23;19(4):null
pubmed: 29570666
Semin Oncol. 2017 Jun;44(3):187-197
pubmed: 29248130
Clin Oncol (R Coll Radiol). 2018 Aug;30(8):472-483
pubmed: 29735311
Oncotarget. 2018 Apr 13;9(28):19463-19468
pubmed: 29731958
Future Oncol. 2016 Sep;12(18):2071-5
pubmed: 27241581
JAMA Oncol. 2016 Apr;2(4):482-90
pubmed: 26720728
Crit Rev Oncol Hematol. 2019 Aug;140:67-72
pubmed: 31176273
Diagnostics (Basel). 2019 May 18;9(2):null
pubmed: 31109041